Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson's disease patients

被引：0
|
作者：
Antonini, A.
Poewe, W.
Standaert, D.
Zadikoff, C.
Dubow, S.
Bergmann, L.
Yegin, A.
Hall, C.
Robieson, W.
Felipe, V.
Barbato, L.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1340
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review
    Wirdefeldt, Karin
    Odin, Per
    Nyholm, Dag
    CNS DRUGS, 2016, 30 (05) : 381 - 404
  • [32] Rationale and design of an open-label, randomised, 26-week study comparing levodopa-carbidopa intestinal gel to optimized medical treatment on non-motor symptoms in patients with advanced Parkinson's disease - INSIGHTS study
    Chaudhuri, K. R.
    Weintraub, D.
    Antonini, A.
    Robieson, W.
    Li, M.
    Chatamra, K.
    Benesh, J.
    Facheris, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 315 - 315
  • [33] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [34] Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Udd, Marianne
    Lyytinen, Jukka
    Eerola-Rautio, Johanna
    Kenttamies, Anu
    Lindstrom, Outi
    Kylanpaa, Leena
    Pekkonen, Eero
    BRAIN AND BEHAVIOR, 2017, 7 (07):
  • [35] Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
    Palhagen, Sven E.
    Sydow, Olof
    Johansson, Anders
    Nyholm, Dag
    Holmberg, Bjorn
    Widner, Hakan
    Dizdar, Nil
    Linder, Jan
    Hauge, Tove
    Jansson, Rasmus
    Bergmann, Lars
    Kjellander, Susanna
    Marshall, Thomas S.
    PARKINSONISM & RELATED DISORDERS, 2016, 29 : 17 - 23
  • [36] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
    Francesc Valldeoriola
    María José Catalán
    Francisco Escamilla-Sevilla
    Eric Freire
    Jesús Olivares
    Esther Cubo
    Diego Santos García
    Matilde Calopa
    Pablo Martínez-Martín
    Juan Carlos Parra
    Gloria Arroyo
    José Matías Arbelo
    npj Parkinson's Disease, 7
  • [37] 24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
    Belinda Cruse
    Hugo Morales-Briceño
    Florence C F Chang
    Neil Mahant
    Ainhi D Ha
    Samuel D Kim
    Nigel Wolfe
    Vu Kwan
    David S Tsui
    Jane M Griffith
    Donna Galea
    Victor S C Fung
    npj Parkinson's Disease, 4
  • [38] 24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson's disease
    Cruse, Belinda
    Morales-Briceno, Hugo
    Chang, Florence C. F.
    Mahant, Neil
    Ha, Ainhi D.
    Kim, Samuel D.
    Wolfe, Nigel
    Kwan, Vu
    Tsui, David S.
    Griffith, Jane M.
    Galea, Donna
    Fung, Victor S. C.
    NPJ PARKINSONS DISEASE, 2018, 4
  • [39] Levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations: Interim quality-of-life endpoints in an ongoing, open-label study
    Standaert, D. G.
    Fernandez, H. H.
    Odin, P.
    Hauser, R. A.
    Espay, A. J.
    Hass, S.
    Robieson, W. Z.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S140 - S140
  • [40] Interim results of quality-of-life endpoints of an open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations
    Standaert, D. G.
    Espay, A. J.
    Fernandez, H. H.
    Benesh, J.
    Lenz, R. A.
    Pritchett, Y. L.
    Hass, S.
    Chatamra, K.
    MOVEMENT DISORDERS, 2011, 26 : S141 - S142
12345